Thromb Haemost 1977; 38(03): 0677-0684
DOI: 10.1055/s-0038-1651883
Original Article
Schattauer GmbH

Effect of Calcium ion on the interaction between Thrombin and Heparin. Thermal Denaturation

Raymund Machovich
1   Postgraduate Medical School, First Department of Medicine, 1389 Budapest and Institute of Biochemistry II, Semmelweis University Medical School, 1088 Budapest, Hungary
,
Péter Arányi
1   Postgraduate Medical School, First Department of Medicine, 1389 Budapest and Institute of Biochemistry II, Semmelweis University Medical School, 1088 Budapest, Hungary
› Author Affiliations
Further Information

Publication History

Received 05 February 1977

Accepted 10 June 1977

Publication Date:
04 July 2018 (online)

Summary

Heat inactivation of thrombin at 54° C followed first order kinetics with a rate constant of 1.0 min−1 approximately. Addition of heparin resulted in protection against thermal denaturation and, at the same time, rendered denaturation kinetics more complex. Analysis of the biphasic curve of heat inactivation in the presence of heparin revealed that the rate constants of the second phase changed systematically with heparin concentrations. Namely, at 4.5 × 10−6M, 9 × 10−6M, 1.8 × 10−5M and 3.6 × 10−5M heparin concentrations, the rate constants were 0.27 min−1, 0.17 min−1, 0.11 min−1 and 0.06 min−1, respectively.

Sulfate as well as phosphate ions displayed also enzyme protection against heat inactivation, however, the same effect was obtained already at a heparin concentration, lower by three orders of magnitude.

The kinetics of enzyme denaturation was not affected by calcium ions, whereas in the presence of heparin the inactivation rate of thrombin changed, i. e. calcium ions abolished the biphasic character of time course of thermal denaturation.

Thus, the data suggest that calcium ions contribute to the effect of heparin on thrombin.

 
  • References

  • 1 Björk I, Nordenman B. 1976; Acceleration of the reaction between thrombin and antithrombin-III by non-stoichiometric amounts of heparin. European Journal of Biochemistry 68: 507.
  • 2 Danishefsky I, Tzeng F, Ahrens M, Klein S. 1976; Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor. Thrombosis Research 8: 131.
  • 3 Einarsson R, Andersson L.-O. 1977; Binding of heparin to human antithrombin-III as studied by measurements of tryptophan fluorescence. Biochimica et Biophysica Acta 490: 104.
  • 4 Furberg S, Solbakk J. 1974; On the stereochemistry of the interaction between nucleic acids and basic protein side chains. Acta Chemica Scandinavica 28: 481.
  • 5 Gelman R. A, Blackwell J. 1973; Heparin-polypeptide interactions in aqueous solution. Archives of Biochemistry and Biophysics 159: 427.
  • 6 Gentry P. W, Alexander B. 1973; Specific coagulation factor adsorption to insoluble heparin. Biochemical and Biophysical Research Communications 50: 500.
  • 7 Hatton M. W. C, Regoeczi E. 1977; The inactivation of thrombin and plasmin by antithrombin-III in the presence of sepharose-heparin. Thrombosis Research 10: 645.
  • 8 Höök M, Björk I, Hopwood J, Lindahl U. 1976; Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Letters 66: 90.
  • 9 Johnson E. A, Kirkwood T. B. L, Stirling Y, Perez-Requejo J. L, Ingram G. I. C, Bangham D. R, Brozovic M. 1976; Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection. Thrombosis and Haemostasis 35: 586.
  • 10 Lam L. H, Silbert J. E, Rosenberg R. D. 1976; The separation of active and inactive forms of heparin. Biochemical and Biophysical Research Communications 69: 570.
  • 11 Li E. H. H, Orton Ch, Feinman R. D. 1974; The interaction of thrombin and heparin. Proflavine dye binding studies. Biochemistry 13: 5012.
  • 12 Lowry O. H, Rosenbrough N. L, Farr A. L, Randall R. 1951; Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 193: 265.
  • 13 Lundblad R. L. 1975; The reaction of bovine thrombin with N-butyrylimidazole. Two different reactions resulting in the inhibition of catalytic activity. Biochemistry 14: 1033.
  • 14 Lundblad R. L, Uhteg L. C, Vogel C. N, Kingdon H. S, Mann K. G. 1975; Preparation and partial characterisation of two forms of bovine thrombin. Biochemical and Biophysical Research Communications 66: 482.
  • 15 Machovich R. 1975; a Mechanism of action of heparin through thrombin on blood coagulation. Biochimica et Biophysica Acta 412: 13.
  • 16 Machovich R. 1975; b Heparin sensitive and non-sensitive forms of thrombin. Biochimica et Biophysica Acta 400: 62.
  • 17 Machovich R, Blaskó Gy, Arányi P. 1975; a The interaction of thrombin and heparin. Heat inactivation kinetics. Thrombosis Research 7: 253.
  • 18 Machovich R, Blaskó Gy, Pálos A. L. 1975; b Action of heparin on thrombin-antithrombin reaction. Biochimica et Biophysica Acta 379: 193.
  • 19 Machovich R, Blaskó Gy, Himer Á, Szikla K. 1975; c Effect of sodium and potassium ions on the human antithrombin-heparin cofactor. Thrombosis Research 7: 305.
  • 20 Machovich R. 1976; Effect of calcium phosphate on thrombin and on its sensitivity to heparin and antithrombin-III. Thrombosis Research 9: 123.
  • 21 Machovich R, Blaskó Gy, Borsodi A. 1976; Inactivation of α- and β-thrombin by antithrombin-III and heparin. Thrombosis and Haemostasis 36: 503.
  • 22 Mann K. G, Yip R, Heldebrant C. M, Fass D. N. 1973; Multiple active forms of thrombin. Journal of Biological Chemistry 248: 1868.
  • 23 Markwardt F, Landman I. 1971. Blutgerinnungshemmende Proteine, Peptide und Aminosäurederivate. Handbuch der experimentellen Pharmakologie, XXVII Anticoagulantien. Springer-Verlag; Berlin – Heidelberg – New York: 84.
  • 24 McDuffie N. M, Dietrich C. P, Nader H. B. 1975; Electrofocusing of heparin: fractionation of heparin into 21 components distinguishable from other acidic mucopolysaccharides. Biopolymers 14: 1473.
  • 25 Pálos Á. L. 1949; Protecting effect of heparin on the inactivation of thrombin by heat. Proceedings of the Society for Experimental Biology and Medicine 71: 471.
  • 26 Rodén L, Baker J, Cifonelli J. A, Mathews M. B. 1972; Isolation and characterisation of connective tissue polysaccharides. Methos in Enzymology 28: 73.
  • 27 Rosenberg R. D, Damus P. S. 1973; The purification and mechanism of action of human anti-thrombin-heparin cofactor. Journal of Biological Chemistry 248: 6490.
  • 28 Smith G. F. 1977; The heparin-thrombin complex in the mechanism of thrombin inactivation by heparin. Biochemical and Biophysical Research Communications 77: 111.
  • 29 Thaler E, Schmer G. 1975; A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods. British Journal of Haematology 31: 233.
  • 30 Wickett R, Li H. J, Isenberg J. 1972; Salt effect of histone IV conformation. Biochemistry 11: 2952.
  • 31 Yuan L, Stivala S. S. 1975; Three dimensional-model of heparin. Advances in Experimental Medicine and Biology 52: 39.